Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment

por Li, Jing, Ferris, Robert L
Publicado 2014

PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment

por Li, Jing, Ferris, Robert L
Publicado 2014

PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL

por Shayan, Gulidanna, Ferris, Robert L
Publicado 2015

IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells

por Concha-Benavente, Fernando, Ferris, Robert L
Publicado 2014

Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy

por Concha-Benavente, Fernando, Ferris, Robert L.
Publicado 2017

Immunotherapy for Head and Neck Squamous Cell Carcinoma

por Moskovitz, Jessica, Moy, Jennifer, Ferris, Robert L.
Publicado 2018

Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells

por Gao, Yang, Trivedi, Sumita, Ferris, Robert L., Koide, Kazunori
Publicado 2014

Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and ne...

por Srivastava, Raghvendra M, Clump, David A, Ferris, Robert L
Publicado 2015

Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations

por Davis, Ruth J., Ferris, Robert L., Schmitt, Nicole C.
Publicado 2016

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment

por Jie, Hyun-Bae, Li, Jing, Srivastava, Raghvendra, Ferris, Robert L
Publicado 2013

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

por Li, Jing, Srivastava, Raghvendra M., Ettyreddy, Abhinav, Ferris, Robert L.
Publicado 2015

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells

por Ming Lim, Chwee, Stephenson, Ryan, Salazar, Andres M, Ferris, Robert L
Publicado 2013

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3

por Concha-Benavente, Fernando, Srivastava, Raghvendra M, Ferrone, Soldano, Ferris, Robert L
Publicado 2013

STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients

por Srivastava, Raghvendra M, Jie, Hyun-bae, Ferrone, Soldano, Ferris, Robert L
Publicado 2013

PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer

por Concha-Benavente, Fernando, Srivastava, Raghvendra M, Kansy, Benjamin, Ferris, Robert L
Publicado 2015

Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

por Folaron, Margaret, Merzianu, Mihai, Duvvuri, Umamaheswar, Ferris, Robert L., Seshadri, Mukund
Publicado 2019

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer

por Vargo, John A., Ferris, Robert L., Clump, David A., Heron, Dwight E.
Publicado 2014

Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands

por Janjic, Bratislav M., Kulkarni, Aditi, Ferris, Robert L., Vujanovic, Lazar, Vujanovic, Nikola L.
Publicado 2022

Stereotactic Ablative Radiosurgery for Locally Advanced or Recurrent Skull Base Malignancies with Prior External Beam Radiation Therapy

por Xu, Karen M., Quan, Kimmen, Clump, David A., Ferris, Robert L., Heron, Dwight E.
Publicado 2015

Otolaryngology, Head and Neck Surgery

por Yang, Tsung-Lin, Ferris, Robert L., Ogawa, Tetsuya, Hwang, Peter, Tong, Michael, Chen, Mu-Kuan
Publicado 2014